RT @EU_Health: #EHDS will be a game changer.
Not only providing access to better treatment for patients who will become the owners of their data, but also fostering innovation in health.
- @SandraGallina at @DIGITALEUROPE's #MoD2023 today.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633809055239077888
RT @EC_HERA: Head of HERA Pierre Delsaux visits @ECDC_EU in Stockholm.
Both HERA and ECDC are committed to continue the close collaboration on targeting health threats and strengthening 🇪🇺 health security.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633774545814388737
RT @GasteinForum: 🚨 Reminder: Join us Monday 13 March online from 18:00 to discuss the revision of the 🇪🇺 #PharmaLegislation with @johannes_rauch, @chrisfearne, @SKyriakidesEU, Emer Cooke @EMA_News, Sylvia Maurer @beuc, @KarlavanRooijen & @AdrianMEDSforEU
✍️ Register: https://docs.google.com/forms/d/e/1FAIpQLSdnLVS_edHlRsL4mNBzFR5iCnODpdm9cpDtMLs3LRF03fJ9rQ/viewform
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633773148649684993
RT @WHO_Europe: Today we celebrate the millions of women who form the backbone of the health and care sector in the WHO European Region.
With women comprising 78% of the workforce, let's recognize their hard work, dedication, and contributions to #HealthForAll
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633428428237029376
We are very proud to celebrate the women who work at EMA! ✨
Today, meet Francesca Day, Head of the Therapeutic Areas 💊🩺 in the Agency.
Listen to what she has to say on career opportunities!
#IWD2023 #InternationalWomensDay #EUWomenInScience
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633421298725519361
RT @WHO_Europe: Today on #InternationalWomensDay, let's acknowledge the incredible contributions women make to the health sector, despite holding only 25% of senior roles.
It's time to empower women to lead in healthcare!
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633407161240829957
RT @EU_ECHA: Happy #InternationalWomensDay 👩🏼🔬! We've invited some #EUWomen from #ECHA, @EMA_News, @EFSA_EU, @euenvironment and @ECDC_EU to give tips to young women pursuing a career in science. Let's all #EmbraceEquity and work towards a more inclusive and innovative future in science.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633387085326344193
Today #EUAgencies are celebrating women and their achievements. But more needs to be done to reach full gender equality and equity.
On this #InternationalWomen'sDay, let's all fully #EmbraceEquity.
#IWD2023 #EmbraceEquity #UnitedInDiversity #EUAgencies
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633377763829891074
RT @hans_kluge: ✅EU Global Health Strategy @EU_Health & @EC_HERA -includes intensifying AMR efforts
✅Future pandemic agreement -a unique opportunity to make global progress, including developing new antibiotics
✅European Roadmap on AMR
⏩3 important multilateral mechanisms to boost action
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633093608734699521
RT @sweden2023eu: Today & tomorrow, the Swedish presidency is hosting a high-level meeting on #AntimicrobialResistance in Stockholm.
Agenda⬇️
📌The EU's contribution to work at global level to curb AMR
📌Sustainable access to existing and stimulation of
development of new antibiotics
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633062724514004992
RT @EU_Health: " We need to assess the cost of inaction on the fight against #AMR & balance it with the need for urgent response to this silent pandemic. And we have not seen any alternatives to vouchers. "
- @SandraGallina at @sweden2023eu's high-level conference today
🐦🔗: https://n.respublicae.eu/EMA_News/status/1633062541290078208
RT @EAAD_EU: To see more in-depth data on #AMR check:
- the latest report here: https://bit.ly/3mnlgn7
- an interactive data visualisation tool showing resistance levels in humans, animals and food, country by country: https://multimedia.efsa.europa.eu/dataviz-2021/index.htm
🐦🔗: https://n.respublicae.eu/EMA_News/status/1632748855530868739
RT @ECDC_Outbreaks: #JustPublished!
@ECDC_EU de-escalates #Omicron BA.2, BA.4 and BA.5 from its list of variants of concern, as these parental lineages are no longer circulating.
Read more here: https://www.ecdc.europa.eu/en/news-events/ecdc-de-escalates-ba2-ba4-and-ba5-its-list-variants-concern
#COVID19 #SARSCoV2
🐦🔗: https://n.respublicae.eu/EMA_News/status/1632659311276040193
RT @EU_HaDEA: Check out the 6 call topics under #HorizonEU #healthresearch destination 5-Unlocking the potential of new tools & technologies for a healthy society, on:
🟣Person-centred health
🟣European #healthdata space
🟣Personalised medicine
🟣Pandemic preparedness
https://hadea.ec.europa.eu/calls-proposals/horizon-europe-health-calls-2023-destination-5-unlocking-full-potential-new-tools-technologies-and_en
🐦🔗: https://n.respublicae.eu/EMA_News/status/1630917881822150656
EMA is committed to support patients living with a rare disease.
The orphan medicines programme for #rarediseases has helped to stimulate the development of new treatments. In over 20 years more than 2⃣3⃣0⃣ have been authorised in the 🇪🇺.
Find out more➡️ https://www.ema.europa.eu/en/human-regulatory/overview/orphan-designation-overview#rare-diseases-at-a-glance-section
🐦🔗: https://n.respublicae.eu/EMA_News/status/1630614446690254862
RT @rarediseaseday: Time for Africa and Europe to mark #RareDiseaseDay 2023!
TV broadcasts, radio podcasts, public transport visuals… Through various means, the community is sharing our call for equity everywhere! Are you also ready to share your colours 💙💚💜?
🐦🔗: https://n.respublicae.eu/EMA_News/status/1630517768742223874
RT @eurordis: Today is @rarediseaseday!
Join us and our colleagues at the Plateforme Maladies Rares in Paris in calling for equity for the rare disease community this #RareDiseaseDay!
@AllianceMR @Telethon_France @fdmaladiesrares @maladierareinfo @Orphanet
🐦🔗: https://n.respublicae.eu/EMA_News/status/1630493974241714176
RT @ECDC_Outbreaks: Our weekly bulletin for epidemiologists and health professionals on active public health threats is out!
This issue covers:
- updates on the earthquake in Türkiye and Syria,
- #COVID19,
- #InfluenzaA (H5N1),
- Group A streptococcal infection,
- #cholera
🐦🔗: https://n.respublicae.eu/EMA_News/status/1630173321806446594
RT @GasteinForum: 📢 There are still spaces to participate online in our upcoming event "Revision of the EU general pharmaceutical legislation - addressing challenges, seizing opportunities" organised in cooperation with @bmsgpk & @AustriaatEU
🗓️ 13 March, 18:00 CET
✍️ https://docs.google.com/forms/d/e/1FAIpQLSdnLVS_edHlRsL4mNBzFR5iCnODpdm9cpDtMLs3LRF03fJ9rQ/viewform
🐦🔗: https://n.respublicae.eu/EMA_News/status/1630173198804303878
📢EMA's human medicines committee, the #CHMP, recommended 8⃣ new #medicines for approval in the 🇪🇺 including:
☑️ three medicines for #cancer
☑️ one medicine for #Fabry disease
☑️ one medicine for facial #angiofibroma
#PublicHealth 👇
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-february-2023
🐦🔗: https://n.respublicae.eu/EMA_News/status/1629085367843401732
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.